A comprehensive set of per-protocol analyses of the myocardial ischemia and transfusion (MINT) trial

Area of Science:

• Cardiology
• Clinical Trials
• Medical Interventions

Background:

• Transfusion strategies are critical in managing patients with myocardial infarction (MI).
• The optimal hemoglobin threshold for red blood cell transfusion remains debated.
• The Myocardial Ischemia and Transfusion (MINT) trial investigated restrictive versus liberal transfusion strategies.

Purpose of the Study:

• To estimate the per-protocol effect of restrictive versus liberal transfusion strategies.
• To assess the impact on 30-day mortality and the composite outcome of death or recurrent MI.
• To compare different analytical methods for estimating treatment effects.

Main Methods:

• Per-protocol effect estimation using adherence data (site-reported, time-based, transfusion delay).
• Instrumental variable analysis to address potential biases.
• Analysis of data from the Myocardial Ischemia and Transfusion (MINT) trial.

Main Results:

• Adherence-based analyses indicated a higher risk of 30-day death or recurrent MI with a restrictive transfusion strategy.
• Instrumental variable analysis yielded a moderate treatment effect, consistent with the original intention-to-treat (ITT) findings.
• Discrepancies observed between different per-protocol estimation methods.

Conclusions:

• The per-protocol effect of transfusion strategies may differ based on analytical methods used.
• Restrictive transfusion strategies might be associated with increased adverse events in certain patient populations.
• Further research is needed to clarify the optimal transfusion threshold in acute coronary syndromes.